查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621823

电子处方市场：按产品、交付模式和最终用户划分 - 全球预测，2025-2030 年

ePrescribing Market by Offrings (Services, Solution), Delivery Mode (On premise, Web & Cloud based), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，电子处方市场价值为1.4753亿美元，预计到2024年将达到1.5921亿美元，复合年增长率为8.05%，预计到2030年将达到2.5379亿美元。

电子处方或电子配药是指医疗处方笺的数位化创建、传输和填写，简化了医疗服务提供者和药房之间的流程。该技术对于减少处方笺错误、提高病人安全和提高医疗保健效率至关重要。电子处方系统通常应用于医院、诊所和药局。在最终用户中，医院因其处方笺量大而占据了很大的市场占有率，但小型诊所和零售药局的采用率也有所增加。市场的关键成长要素包括对医疗保健 IT 解决方案的需求不断增加、对减少用药错误的日益关注以及政府为加速采用电子处方而做出的努力。向远端医疗的日益转变和不断扩大的互通性标准带来了显着的机会，为新参与企业和现有企业提供了针对不同医疗保健环境创新和客製化解决方案的途径。为了利用这些机会，公司可以探索诸如整合人工智慧进行个人化药物管理、增强安全功能以及改进用户介面以提高易用性等方法。然而，这个市场面临一些挑战，例如与现有电子健康记录(EHR) 系统的整合、初始投资较高以及对资料隐私和安全的担忧。另一个限制是一些医疗专业人员抵制学习新技术。此外，不同地区的法规不同可能会使市场扩大策略变得复杂。研究和开发应专注于为小型诊所开发具有成本效益的解决方案，提高资料共用能力，并确保遵守不断变化的监管标准。对用于安全交易的区块链和用于预测分析的机器学习的研究可以进一步推动市场发展。总体而言，市场是充满活力的，其特点是逐渐走向全面数位健康整合，为能够有效管理当前限制并利用我们提供的新兴技术的公司提供了巨大的成长潜力。

主要市场统计
基准年[2023] 14753万美元
预测年份 [2024] 1.5921亿美元
预测年份 [2030] 2.5379亿美元
复合年增长率（%） 8.05%

市场动态：揭示快速发展的电子处方市场的关键市场洞察

供需的动态交互作用正在改变电子处方市场。了解这些不断变化的市场动态可以帮助公司做出明智的投资决策、改善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 促进电子配製系统使用的政府措施和法规
    • 更多采用电子健康记录(EHR)
    • 对提高护理品质和病人安全的需求不断增长
  • 市场限制因素
    • 初始设定和维护成本很高
  • 市场机会
    • 加大投资拓展新兴地区业务，推动决策支援系统
    • 与远端医疗的整合以及个人化医疗分析的利用
  • 市场问题
    • 对资料隐私和安全的担忧

波特五力：驾驭电子处方市场的策略工具

波特五力：「框架是了解市场格局竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解电子处方市场的外部影响

外部宏观环境因素在塑造电子处方市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解电子处方市场的竞争格局

对电子处方市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：电子处方市场供应商的绩效评估

FPNV 定位矩阵是评估电子处方市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製电子处方市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对电子处方市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 促进电子配製系统使用的政府措施和法规
      • 更多采用电子健康记录 (EHR)
      • 提高护理品质和病人安全的新要求
    • 抑制因素
      • 初始设定和维护成本很高
    • 机会
      • 扩大新兴地区投资，改善决策支援系统
      • 与远端医疗整合并利用分析实现个人化医疗
    • 任务
      • 资料隐私和安全问题
  • 市场区隔分析
    • 组件：整合解决方案适用于更广泛的医疗保健 IT 系统
    • 部署：即时资料共用和更新推动云端的采用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第 6 章 电子处方市场提供来源：透过提供

  • 介绍
  • 服务
    • 执行
    • 网路
  • 解决方案
    • 一体化
    • 独立的

第七章电子处方市场：依交付模式

  • 介绍
  • 本地
  • 云端基础

第 8 章 电子处方市场：依最终使用者划分

  • 介绍
  • 医院
  • 药局
  • 医生办公室

第九章美洲电子处方市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区电子处方市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的电子处方市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Rhyl 为患者推出新的电子处方笺系统
    • DrFirst Healthcare Innovations 与 MEDITECH 合作推进加拿大的电子复合
    • BoomerangFX 与 DrFirst 合作，为北美美容医疗诊所推出电子配药
  • 战略分析和建议

公司名单

  • 75health
  • Allscripts Healthcare Solutions Inc.
  • athenahealth, Inc.
  • Dosespot by PRN Software, LLC
  • DrChrono
  • DrFirst Inc.
  • eazyScripts Technology, LLC
  • eClinicalWorks
  • eMDs, Inc. by CompuGroup Medical
  • Epocrates Inc.
  • Healthie Inc.
  • iCoreConnect
  • Intelligent Medical Software
  • Kareo, Inc. by Tebra Technologies, Inc.
  • MDToolbox
  • MedicalMine Inc.
  • Networking Technology, Inc.
  • NextGen Healthcare, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Pabau
  • Provet Cloud
  • Qualifacts Systems, LLC
  • Surescripts, LLC
  • Wolters Kluwer NV
Product Code: MRR-351BAD5037B5

The ePrescribing Market was valued at USD 147.53 million in 2023, expected to reach USD 159.21 million in 2024, and is projected to grow at a CAGR of 8.05%, to USD 253.79 million by 2030.

ePrescribing, or electronic prescribing, refers to the digital creation, transmission, and filling of medical prescriptions, streamlining the process between healthcare providers and pharmacies. This technology is essential for reducing prescription errors, enhancing patient safety, and improving healthcare efficiency. ePrescribing systems are typically applied in hospitals, clinics, and pharmacies. Among end users, hospitals hold significant market share due to high prescription volume, but adoption is expanding across smaller practices and retail pharmacies. Key growth factors in the market include rising demand for healthcare IT solutions, increased focus on reducing medication errors, and government initiatives promoting the adoption of ePrescribing. The ongoing shift towards telemedicine and expanding interoperability standards present notable opportunities, providing avenues for new entrants and established players to innovate and tailor solutions for varied healthcare settings. To capitalize on these opportunities, companies can explore integrating AI for personalized medication management, enhancing cybersecurity features, and improving user interfaces for better usability. However, the market faces challenges such as integration with existing electronic health record (EHR) systems, high initial investments, and concerns regarding data privacy and security. Limitations also include resistance from some healthcare professionals due to the learning curve associated with new technology. Furthermore, regulatory variations across different regions can complicate market expansion strategies. Innovation and research should focus on developing cost-effective solutions aimed at smaller practices, improving data-sharing capabilities, and ensuring compliance with evolving regulatory standards. Research into blockchain for secure transactions and machine learning for predictive analytics could further drive market evolution. Overall, the market is dynamic, characterized by a progressive trend towards full digital health integration, offering substantial growth potential for those who can effectively manage current limitations and leverage emerging technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 147.53 million
Estimated Year [2024] USD 159.21 million
Forecast Year [2030] USD 253.79 million
CAGR (%) 8.05%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving ePrescribing Market

The ePrescribing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and regulations promoting the use of e-prescribing systems
    • Increasing adoption of electronic health records (EHRs)
    • Emerging demand for improved healthcare quality and patient safety
  • Market Restraints
    • High initial setup and maintenance costs
  • Market Opportunities
    • Rising investments to expand in emerging regions, and advancements in decision support systems
    • Integration with telemedicine, leveraging analytics for personalized medicine
  • Market Challenges
    • Concerns about data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the ePrescribing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the ePrescribing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the ePrescribing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the ePrescribing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the ePrescribing Market

A detailed market share analysis in the ePrescribing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the ePrescribing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the ePrescribing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the ePrescribing Market

A strategic analysis of the ePrescribing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the ePrescribing Market, highlighting leading vendors and their innovative profiles. These include 75health, Allscripts Healthcare Solutions Inc., athenahealth, Inc., Dosespot by PRN Software, LLC, DrChrono, DrFirst Inc., eazyScripts Technology, LLC, eClinicalWorks, eMDs, Inc. by CompuGroup Medical, Epocrates Inc., Healthie Inc., iCoreConnect, Intelligent Medical Software, Kareo, Inc. by Tebra Technologies, Inc., MDToolbox, MedicalMine Inc., Networking Technology, Inc., NextGen Healthcare, Inc., Optum, Inc., Oracle Corporation, Pabau, Provet Cloud, Qualifacts Systems, LLC, Surescripts, LLC, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the ePrescribing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offrings, market is studied across Services and Solution. The Services is further studied across Implementation and Network. The Solution is further studied across Integrated, and Standalone.
  • Based on Delivery Mode, market is studied across On premise and Web & Cloud based.
  • Based on End User, market is studied across Hospitals, Pharmacies, and Physician Offices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and regulations promoting the use of e-prescribing systems
      • 5.1.1.2. Increasing adoption of electronic health records (EHRs)
      • 5.1.1.3. Emerging demand for improved healthcare quality and patient safety
    • 5.1.2. Restraints
      • 5.1.2.1. High initial setup and maintenance costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments to expand in emerging regions, and advancements in decision support systems
      • 5.1.3.2. Integration with telemedicine, leveraging analytics for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns about data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Suitability of integrated solutions for broader healthcare IT system
    • 5.2.2. Deployment: Inclination towards on-cloud deployment owing to real time data sharing and updates
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. ePrescribing Market, by Offrings

  • 6.1. Introduction
  • 6.2. Services
    • 6.2.1. Implementation
    • 6.2.2. Network
  • 6.3. Solution
    • 6.3.1. Integrated,
    • 6.3.2. Standalone

7. ePrescribing Market, by Delivery Mode

  • 7.1. Introduction
  • 7.2. On premise
  • 7.3. Web & Cloud based

8. ePrescribing Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Pharmacies
  • 8.4. Physician Offices

9. Americas ePrescribing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ePrescribing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ePrescribing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Rhyl to Launch New Electronic Prescription System for Patients
    • 12.3.2. DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada
    • 12.3.3. BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 75health
  • 2. Allscripts Healthcare Solutions Inc.
  • 3. athenahealth, Inc.
  • 4. Dosespot by PRN Software, LLC
  • 5. DrChrono
  • 6. DrFirst Inc.
  • 7. eazyScripts Technology, LLC
  • 8. eClinicalWorks
  • 9. eMDs, Inc. by CompuGroup Medical
  • 10. Epocrates Inc.
  • 11. Healthie Inc.
  • 12. iCoreConnect
  • 13. Intelligent Medical Software
  • 14. Kareo, Inc. by Tebra Technologies, Inc.
  • 15. MDToolbox
  • 16. MedicalMine Inc.
  • 17. Networking Technology, Inc.
  • 18. NextGen Healthcare, Inc.
  • 19. Optum, Inc.
  • 20. Oracle Corporation
  • 21. Pabau
  • 22. Provet Cloud
  • 23. Qualifacts Systems, LLC
  • 24. Surescripts, LLC
  • 25. Wolters Kluwer N.V.

LIST OF FIGURES

  • FIGURE 1. EPRESCRIBING MARKET RESEARCH PROCESS
  • FIGURE 2. EPRESCRIBING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPRESCRIBING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPRESCRIBING MARKET DYNAMICS
  • TABLE 7. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPRESCRIBING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPRESCRIBING MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPRESCRIBING MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPRESCRIBING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPRESCRIBING MARKET SIZE, BY INTEGRATED,, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPRESCRIBING MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPRESCRIBING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPRESCRIBING MARKET SIZE, BY WEB & CLOUD BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPRESCRIBING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPRESCRIBING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPRESCRIBING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023